- Dr. Lisa Diller comments on adults who suffer health consequences from their cancer treatment as children.
- Dana-Farber President Dr. Edward J. Benz, Jr., and Michael Goldberg, PhD, have been working on a financial innovation to fund cancer research through the securitization technique.
- Dr. Ursula Matulonis has received a $900,000 grant from the Ovarian Cancer Research Foundation to test new combinations of targeted drugs against the disease.
- Dr. Ursula Matulonis commented on a study that found women with BRCA-1 mutations can reduce their risk of breast and ovarian cancer if they get their ovaries removed by age 35.
Tags: BreastCancer, OvarianCancer, Genetics
- Dr. Sarah Feldman comments on the often-confusing guidelines as to which women need routine Pap tests. Pap tests are used to check for cervical cancer.
- The Swiss drug giant Novartis AG has bought two-year-old CoStim Pharmaceuticals Inc., a venture-backed Cambridge biotech using research from scientists including Dr. Gordon Freeman.
Tags: BasicResearch, Immunotherapy
- Dr. Gordon Freeman says many new cancer therapies being tested by drug companies exist thanks to federally backed basic science conducted at U.S. universities.
- Checkpoint inhibitors seem to be providing uniquely long-term benefits for cancer patients. “The field is just afire now,” says immunologist Dr. Gordon Freeman.
- Two-time cancer survivor and Pan-Mass Challenge rider Dan Haley talks about his experiences as a Dana-Farber patient and PMC fundraiser.
Tags: JimmyFund, PanMassChallenge
- Kathy Giusti, a Dana-Farber patient and founder of the Multiple Myeloma Research Foundation, and Dr. John Quakenbush comment on Boston's prominence in the world of biotech research.
Showing 21-30 of 376 items